Showing results (341-350 of 420) with videos related to
Sort By:
Pageof 42
Cytometry. Part B, Clinical Cytometry|April 27, 2004
A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypesE Paietta, O Goloubeva, D Neuberg, et al.British Journal of Haematology|March 6, 1998
Acute myeloid leukaemia expressing the leucocyte integrin CD11b-a new leukaemic syndrome with poor prognosis: result of an ECOG database analysis. Eastern Cooperative Oncology GroupE Paietta, J Andersen, J Yunis, et al.Cancer|July 1, 1983
Prolonged venous access for chemotherapy by means of the Hickman catheterW P Reed, K A Newman, C de Jongh, et al.Annals of Internal Medicine|March 1, 1981
The late appearance of chronic pericardial disease in patients treated by radiotherapy for Hodgkin's diseaseM M Applefeld, J F Cole, S H Pollock, et al.Cancer|October 15, 1980
Cis-Dichlorodiammine platinum and adriamycin therapy for advanced gynecological and genitourinary neoplasmsS Ostrow, M J Egorin, D Hahn, et al.American Journal of Clinical Oncology|June 1, 1982
A phase II trial of m-AMSA in the treatment of advanced gynecologic malignanciesD E Brenner, C Garbino, H Kasdorf, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the Eastern Cooperative Oncology Group experienceM S Tallman, R Gray, J M Bennett, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1983
Trimethoprim/sulfamethoxazole versus placebo: a double-blind comparison of infection prophylaxis in patients with small cell carcinoma of the lungC A de Jongh, J C Wade, R S Finley, et al.American Journal of Clinical Oncology|February 1, 1982
A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lungJ Z Fuks, J Aisner, D N Carney, et al.Leukemia|June 1, 1987
A randomized trial of high dose cyclophosphamide, vincristine, and prednisone plus or minus doxorubicin (CVP versus CAVP) with long-term follow-up in advanced non-Hodgkin's lymphomaJ F Bishop, P H Wiernik, M N Wesley, et al.Pageof 42